Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Weaver

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters|September 30, 2011
Discovery of pyrazoles as novel FPR1 antagonistsAndrew D Morley, Andrew Cook, Sarah King, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2009
Discovery of small molecule human C5a receptor antagonistsHitesh J Sanganee, Andrew Baxter, Simon Barber, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2011
Discovery of small molecule human FPR1 receptor antagonistsJohn Unitt, Malbinder Fagura, Tim Phillips, et al.
Journal of Medical Entomology|November 4, 2020
Evaluation of Lotions of Botanical-Based Repellents Against Aedes aegypti (Diptera: Culicidae)Whitney A Qualls, Rui-De Xue, Muhammad Farooq, et al.
Chemical Research in Toxicology|June 1, 2012
In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugsRichard A Thompson, Emre M Isin, Yan Li, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2006
Discovery of potent CRTh2 (DP2) receptor antagonistsTimothy N Birkinshaw, Simon J Teague, Claire Beech, et al.
Journal of Medicinal Chemistry|October 11, 2019
Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-<i>trans</i>-Dihydro-1,2-diol Metabolites of the Utrophin Modulator EzutromidMaria Chatzopoulou, Tim D W Claridge, Kay E Davies, et al.
Journal of Medicinal Chemistry|October 30, 2007
Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitorsMark Furber, Lilian Alcaraz, Janice E Bent, et al.
Regulatory Toxicology and Pharmacology : RTP|March 4, 2020
Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluationHelen Prior, Paul Baldrick, Sonja Beken, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters|September 30, 2011
Discovery of pyrazoles as novel FPR1 antagonistsAndrew D Morley, Andrew Cook, Sarah King, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2009
Discovery of small molecule human C5a receptor antagonistsHitesh J Sanganee, Andrew Baxter, Simon Barber, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2011
Discovery of small molecule human FPR1 receptor antagonistsJohn Unitt, Malbinder Fagura, Tim Phillips, et al.
Journal of Medical Entomology|November 4, 2020
Evaluation of Lotions of Botanical-Based Repellents Against Aedes aegypti (Diptera: Culicidae)Whitney A Qualls, Rui-De Xue, Muhammad Farooq, et al.
Chemical Research in Toxicology|June 1, 2012
In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugsRichard A Thompson, Emre M Isin, Yan Li, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2006
Discovery of potent CRTh2 (DP2) receptor antagonistsTimothy N Birkinshaw, Simon J Teague, Claire Beech, et al.
Journal of Medicinal Chemistry|October 11, 2019
Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-<i>trans</i>-Dihydro-1,2-diol Metabolites of the Utrophin Modulator EzutromidMaria Chatzopoulou, Tim D W Claridge, Kay E Davies, et al.
Journal of Medicinal Chemistry|October 30, 2007
Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitorsMark Furber, Lilian Alcaraz, Janice E Bent, et al.
Regulatory Toxicology and Pharmacology : RTP|March 4, 2020
Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluationHelen Prior, Paul Baldrick, Sonja Beken, et al.
Pageof 3